<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on November 19, 2021</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT04057794</url>
  </required_header>
  <id_info>
    <org_study_id>PDGene-01</org_study_id>
    <nct_id>NCT04057794</nct_id>
  </id_info>
  <brief_title>PDGeneration: Mapping the Future of Parkinson's Disease</brief_title>
  <acronym>PDGENE</acronym>
  <official_title>Parkinson's Foundation: PD Generation: Mapping the Future of Parkinson's Disease</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>Parkinson's Foundation</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
    <collaborator>
      <agency>University of Rochester - CHeT/CTCC</agency>
      <agency_class>Other</agency_class>
    </collaborator>
    <collaborator>
      <agency>Fulgent Laboratories</agency>
      <agency_class>Other</agency_class>
    </collaborator>
    <collaborator>
      <agency>Indiana University</agency>
      <agency_class>Other</agency_class>
    </collaborator>
    <collaborator>
      <agency>The Parkinson Study Group</agency>
      <agency_class>Other</agency_class>
    </collaborator>
  </sponsors>
  <source>Parkinson's Foundation</source>
  <oversight_info>
    <has_dmc>No</has_dmc>
    <is_fda_regulated_drug>No</is_fda_regulated_drug>
    <is_fda_regulated_device>Yes</is_fda_regulated_device>
    <is_unapproved_device>Yes</is_unapproved_device>
    <is_us_export>No</is_us_export>
  </oversight_info>
  <brief_summary>
    <textblock>
      To assess the feasibility, impact, and participant satisfaction of offering Clinical&#xD;
      Laboratory Improvement Amendments (CLIA) certified genetic testing as part of clinical care&#xD;
      for People with Parkinson's disease (PWP).&#xD;
    </textblock>
  </brief_summary>
  <detailed_description>
    <textblock>
      The purpose of this study is to evaluate how offering Clinical Laboratory Improvement&#xD;
      Amendments (CLIA) certified genetic testing for Parkinson's Disease (PD) genes to people with&#xD;
      Parkinson's Disease impacts clinical care and potential enrollment in clinical trials. This&#xD;
      multi-center study will assess the impact and satisfaction of the mode of genetic counseling&#xD;
      by comparing counseling conducted by a clinician versus centralized genetic counseling&#xD;
      conducted through Indiana University. The study will also assess knowledge gained by&#xD;
      administering a knowledge survey pre- and post-genetic testing. All genetic test results will&#xD;
      be returned to participants through a genetic counseling visit.&#xD;
    </textblock>
  </detailed_description>
  <overall_status>Recruiting</overall_status>
  <start_date type="Actual">August 15, 2019</start_date>
  <completion_date type="Anticipated">April 15, 2025</completion_date>
  <primary_completion_date type="Anticipated">December 15, 2024</primary_completion_date>
  <phase>N/A</phase>
  <study_type>Interventional</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <allocation>Non-Randomized</allocation>
    <intervention_model>Single Group Assignment</intervention_model>
    <intervention_model_description>All participants will undergo genetic counseling service post-genetic testing either locally or through central services.</intervention_model_description>
    <primary_purpose>Screening</primary_purpose>
    <masking>None (Open Label)</masking>
  </study_design_info>
  <primary_outcome>
    <measure>Feasibility</measure>
    <time_frame>up to 24 weeks</time_frame>
    <description>The total number of participants who receive genetic testing and counseling.</description>
  </primary_outcome>
  <primary_outcome>
    <measure>Impact Evaluation</measure>
    <time_frame>up to 6 months</time_frame>
    <description>The impact of knowledge gained by people with Parkinson's by assessing returned survey responses regarding their behavior and follow-up to clinical care after receipt of genetic counseling.</description>
  </primary_outcome>
  <primary_outcome>
    <measure>Satisfaction Comparison</measure>
    <time_frame>up to 6 months</time_frame>
    <description>Differences in satisfaction of receiving genetic test results and genetic counseling by enrolling site (clinician/genetic counselor) or centralized counseling group using the Clinical Genetic Counseling Satisfaction Score.</description>
  </primary_outcome>
  <secondary_outcome>
    <measure>Number of participants that enroll in precision medicine trials</measure>
    <time_frame>up to 12 months</time_frame>
    <description>Number of participants that enroll in precision medicine trials</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Time it takes between first contact to the return of genetic test results</measure>
    <time_frame>up to 12 months</time_frame>
    <description>Number of weeks it takes between participant consent to return of genetic test results.</description>
  </secondary_outcome>
  <number_of_arms>2</number_of_arms>
  <enrollment type="Anticipated">15000</enrollment>
  <condition>Parkinson's Disease and Parkinsonism</condition>
  <arm_group>
    <arm_group_label>Site-Based Genetic Counseling</arm_group_label>
    <arm_group_type>Active Comparator</arm_group_type>
    <description>Participants randomized to this arm will receive genetic counseling for genetic results through the enrolling site.</description>
  </arm_group>
  <arm_group>
    <arm_group_label>Centralized Genetic Counseling</arm_group_label>
    <arm_group_type>Active Comparator</arm_group_type>
    <description>Participants randomized to this arm will receive genetic counseling for genetic results through a centralized genetic counseling group at Indiana University.</description>
  </arm_group>
  <intervention>
    <intervention_type>Device</intervention_type>
    <intervention_name>Lab Assay for seven genetic variants for Parkinson's Disease</intervention_name>
    <description>Counseling provided to participant by site clinician/physician/genetic counselor.</description>
    <arm_group_label>Site-Based Genetic Counseling</arm_group_label>
  </intervention>
  <intervention>
    <intervention_type>Device</intervention_type>
    <intervention_name>Lab Assay for seven genetic variants for Parkinson's Disease</intervention_name>
    <description>Counseling provided to participant by centralized genetic counseling group at Indiana University.</description>
    <arm_group_label>Centralized Genetic Counseling</arm_group_label>
  </intervention>
  <eligibility>
    <criteria>
      <textblock>
        Inclusion Criteria:&#xD;
&#xD;
          1. Meet Movement Disorder Society (MDS) Clinical Diagnostic Criteria for Parkinson's&#xD;
             Disease: probable diagnosis.&#xD;
&#xD;
          2. Willingness to undergo genetic testing, and choose to be informed of genetic testing&#xD;
             results for Glucosylceramidase Beta (GBA), LRRK2 and 5 additional PD related genes&#xD;
             (SNCA, VPS35, PRKN, PINK-1, PARK7).&#xD;
&#xD;
          3. Capacity to give full informed consent in writing, and have read and signed the&#xD;
             informed consent forms (ICFs) based on clinician's determination.&#xD;
&#xD;
          4. Able to perform study activities (including completion of either online, in-person or&#xD;
             paper surveys).&#xD;
&#xD;
          5. Individuals must speak and understand the language of the informed consent.&#xD;
&#xD;
        Exclusion Criteria:&#xD;
&#xD;
          1. Diagnosis of an atypical parkinsonian disorder (i.e., multiple system atrophy,&#xD;
             progressive supranuclear palsy, dementia with Lewy bodies, corticobasal syndrome),&#xD;
             including that due to medications, metabolic disorders, encephalitis, cerebrovascular&#xD;
             disease, or normal pressure hydrocephalus.&#xD;
&#xD;
          2. Individuals who have received a blood transfusion within the past 3 months.&#xD;
&#xD;
          3. Individuals who have active hematologic malignancies such as lymphoma or leukemia.&#xD;
&#xD;
          4. Individuals who have had a bone marrow transplant within the past 5 years.&#xD;
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>18 Years</minimum_age>
    <maximum_age>N/A</maximum_age>
    <healthy_volunteers>No</healthy_volunteers>
  </eligibility>
  <overall_official>
    <last_name>Roy N Alcalay, MD, MS</last_name>
    <role>Principal Investigator</role>
    <affiliation>Columbia University</affiliation>
  </overall_official>
  <overall_contact>
    <last_name>Elizabeth U Lyda, BS</last_name>
    <phone>585-273-4038</phone>
    <email>elizabeth.lyda@chet.rochester.edu</email>
  </overall_contact>
  <overall_contact_backup>
    <last_name>Karen C Hodgeman</last_name>
    <phone>585-273-5365</phone>
    <email>karen.hodgeman@chet.rochester.edu</email>
  </overall_contact_backup>
  <location>
    <facility>
      <name>Barrow Neurological Institute</name>
      <address>
        <city>Phoenix</city>
        <state>Arizona</state>
        <zip>85013</zip>
        <country>United States</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Farah Ismail</last_name>
      <phone>602-406-3343</phone>
      <email>farah.ismail@dignityhealth.org</email>
    </contact>
    <contact_backup>
      <last_name>Ruby Rendon</last_name>
      <phone>602-406-7423</phone>
      <email>ruby.rendon@dignityhealth.org</email>
    </contact_backup>
    <investigator>
      <last_name>Holly Shill, MD</last_name>
      <role>Principal Investigator</role>
    </investigator>
    <investigator>
      <last_name>Guillermo Moguel-Cobos, MD</last_name>
      <role>Sub-Investigator</role>
    </investigator>
  </location>
  <location>
    <facility>
      <name>University of California San Diego (UCSD)</name>
      <address>
        <city>La Jolla</city>
        <state>California</state>
        <zip>92093</zip>
        <country>United States</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Lisa Damron</last_name>
      <phone>858-822-5873</phone>
      <email>ldamron@ucsd.edu</email>
    </contact>
    <contact_backup>
      <last_name>Ileana Rubio</last_name>
      <phone>858-246-2505</phone>
      <email>irubio@ucsd.edu</email>
    </contact_backup>
    <investigator>
      <last_name>Irene Litvan, MD</last_name>
      <role>Principal Investigator</role>
    </investigator>
    <investigator>
      <last_name>David Coughlin, MD</last_name>
      <role>Sub-Investigator</role>
    </investigator>
    <investigator>
      <last_name>Brenton Wright, MD</last_name>
      <role>Sub-Investigator</role>
    </investigator>
    <investigator>
      <last_name>Caitlin Mulligan, MD</last_name>
      <role>Sub-Investigator</role>
    </investigator>
    <investigator>
      <last_name>Katherine Longardener, MD</last_name>
      <role>Sub-Investigator</role>
    </investigator>
  </location>
  <location>
    <facility>
      <name>University of Miami</name>
      <address>
        <city>Fort Lauderdale</city>
        <state>Florida</state>
        <zip>33308</zip>
        <country>United States</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Letty Ginsburg</last_name>
      <phone>954-629-1353</phone>
      <email>lginsburg@miami.edu</email>
    </contact>
    <investigator>
      <last_name>Carlos Singer, MD</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location>
    <facility>
      <name>Cleveland Clinic Florida-Weston</name>
      <address>
        <city>Weston</city>
        <state>Florida</state>
        <zip>33331</zip>
        <country>United States</country>
      </address>
    </facility>
    <status>Not yet recruiting</status>
    <contact>
      <last_name>Sheilla Jerome</last_name>
      <phone>954-659-5671</phone>
      <email>jeromes@ccf.org</email>
    </contact>
    <investigator>
      <last_name>Nestor Galvez-Jimenez, MD</last_name>
      <role>Principal Investigator</role>
    </investigator>
    <investigator>
      <last_name>Tarannum Khan, MD</last_name>
      <role>Sub-Investigator</role>
    </investigator>
  </location>
  <location>
    <facility>
      <name>Northwestern University Feinberg School of Medicine</name>
      <address>
        <city>Chicago</city>
        <state>Illinois</state>
        <zip>60611</zip>
        <country>United States</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Karen Williams</last_name>
      <phone>312-503-5645</phone>
      <email>k-williams8@northwestern.edu</email>
    </contact>
    <contact_backup>
      <last_name>Max Galarce</last_name>
      <phone>312-503-4270</phone>
      <email>max.galarce@northwestern.edu</email>
    </contact_backup>
    <investigator>
      <last_name>Tanya Simuni, MD</last_name>
      <role>Principal Investigator</role>
    </investigator>
    <investigator>
      <last_name>Danny Bega, MD</last_name>
      <role>Sub-Investigator</role>
    </investigator>
    <investigator>
      <last_name>Danielle Larson, MD</last_name>
      <role>Sub-Investigator</role>
    </investigator>
    <investigator>
      <last_name>Niccolo Mencacci, MD</last_name>
      <role>Sub-Investigator</role>
    </investigator>
    <investigator>
      <last_name>Neil Shetty, MD</last_name>
      <role>Sub-Investigator</role>
    </investigator>
  </location>
  <location>
    <facility>
      <name>University of Kansas Medical Center</name>
      <address>
        <city>Kansas City</city>
        <state>Kansas</state>
        <zip>66160</zip>
        <country>United States</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Patricia Brady, RN</last_name>
      <phone>913-588-0013</phone>
      <email>pbrady3@kumc.edu</email>
    </contact>
    <contact_backup>
      <last_name>April Langhammer</last_name>
      <email>alanghammer@kumc.edu</email>
    </contact_backup>
    <investigator>
      <last_name>Rajesh Pahwa, MD</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location>
    <facility>
      <name>Massachusetts General Hospital</name>
      <address>
        <city>Boston</city>
        <state>Massachusetts</state>
        <zip>02129</zip>
        <country>United States</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Remy Johnson</last_name>
      <phone>617-726-4936</phone>
      <email>rhjohnson@mgh.harvard.edu</email>
    </contact>
    <contact_backup>
      <last_name>Mansi Sharma</last_name>
      <phone>508-395-3479</phone>
      <email>msharma13@mgh.harvard.edu</email>
    </contact_backup>
    <investigator>
      <last_name>Anne-Marie Wills, MD</last_name>
      <role>Principal Investigator</role>
    </investigator>
    <investigator>
      <last_name>Michael Schwartzschild, MD/PhD</last_name>
      <role>Sub-Investigator</role>
    </investigator>
    <investigator>
      <last_name>Ann Hunt, MD</last_name>
      <role>Sub-Investigator</role>
    </investigator>
    <investigator>
      <last_name>Albert Hung, MD</last_name>
      <role>Sub-Investigator</role>
    </investigator>
    <investigator>
      <last_name>Todd Herrington, MD</last_name>
      <role>Sub-Investigator</role>
    </investigator>
    <investigator>
      <last_name>Grace Crotty, MD</last_name>
      <role>Sub-Investigator</role>
    </investigator>
  </location>
  <location>
    <facility>
      <name>Health Partners/Park Nicollet: Struthers Parkinson's Center</name>
      <address>
        <city>Minneapolis</city>
        <state>Minnesota</state>
        <zip>55427</zip>
        <country>United States</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Kelsey Peirson</last_name>
      <phone>952-993-5903</phone>
      <email>kelsey.peirson@parknicollet.com</email>
    </contact>
    <investigator>
      <last_name>Martha Nance, MD</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location>
    <facility>
      <name>Beth Israel Medical Center</name>
      <address>
        <city>New York</city>
        <state>New York</state>
        <zip>10003</zip>
        <country>United States</country>
      </address>
    </facility>
    <status>Not yet recruiting</status>
    <contact>
      <last_name>Deborah Raymond, CGC</last_name>
      <email>draymond@chpnet.org</email>
    </contact>
    <contact_backup>
      <last_name>Theresa Lin</last_name>
      <email>theresa.lin@mountsinai.org</email>
    </contact_backup>
    <investigator>
      <last_name>Susan Bressman, MD</last_name>
      <role>Principal Investigator</role>
    </investigator>
    <investigator>
      <last_name>Rachel Saunders-Pullman, MD</last_name>
      <role>Sub-Investigator</role>
    </investigator>
  </location>
  <location>
    <facility>
      <name>Columbia University</name>
      <address>
        <city>New York</city>
        <state>New York</state>
        <zip>10032</zip>
        <country>United States</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Amanda Chan</last_name>
      <phone>212-305-4233</phone>
      <email>akc2177@cumc.columbia.edu</email>
    </contact>
    <investigator>
      <last_name>Roy Alcalay, MD, MSC</last_name>
      <role>Principal Investigator</role>
    </investigator>
    <investigator>
      <last_name>Linn Katus, DO</last_name>
      <role>Sub-Investigator</role>
    </investigator>
    <investigator>
      <last_name>Jill Goldman, CGC</last_name>
      <role>Sub-Investigator</role>
    </investigator>
  </location>
  <location>
    <facility>
      <name>Cleveland Clinic</name>
      <address>
        <city>Cleveland</city>
        <state>Ohio</state>
        <zip>44195</zip>
        <country>United States</country>
      </address>
    </facility>
    <status>Enrolling by invitation</status>
  </location>
  <location>
    <facility>
      <name>University of Pennsylvania</name>
      <address>
        <city>Philadelphia</city>
        <state>Pennsylvania</state>
        <zip>19107</zip>
        <country>United States</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Noah Han</last_name>
      <phone>215-829-6500</phone>
      <email>noah.han@pennmedicine.upenn.edu</email>
    </contact>
    <investigator>
      <last_name>Thomas Tropea, DO, MPH</last_name>
      <role>Principal Investigator</role>
    </investigator>
    <investigator>
      <last_name>Andrew Siderowf, MD</last_name>
      <role>Sub-Investigator</role>
    </investigator>
    <investigator>
      <last_name>Rachel Paul, CGC</last_name>
      <role>Sub-Investigator</role>
    </investigator>
    <investigator>
      <last_name>Tanya BARDAKJIAN, CGC</last_name>
      <role>Sub-Investigator</role>
    </investigator>
  </location>
  <location>
    <facility>
      <name>Baylor College of Medicine</name>
      <address>
        <city>Houston</city>
        <state>Texas</state>
        <zip>77030</zip>
        <country>United States</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Rory Mahabir</last_name>
      <email>rory.mahabir@bcm.edu</email>
    </contact>
    <contact_backup>
      <last_name>Mamie Hylton</last_name>
      <phone>713-798-8513</phone>
      <email>mamie.hylton@bcm.edu</email>
    </contact_backup>
    <investigator>
      <last_name>Nora Vanegas-Arroyave, MD</last_name>
      <role>Principal Investigator</role>
    </investigator>
    <investigator>
      <last_name>Steven Bellows, MD</last_name>
      <role>Sub-Investigator</role>
    </investigator>
    <investigator>
      <last_name>Joseph Jankovic, MD</last_name>
      <role>Sub-Investigator</role>
    </investigator>
    <investigator>
      <last_name>Joshua Shulman, MD, PhD</last_name>
      <role>Sub-Investigator</role>
    </investigator>
    <investigator>
      <last_name>Arjun Tarakad, MD</last_name>
      <role>Sub-Investigator</role>
    </investigator>
  </location>
  <location_countries>
    <country>United States</country>
  </location_countries>
  <link>
    <url>http://www.parkinson.org/PDGENEration</url>
    <description>For more information and to enroll, please visit the website.</description>
  </link>
  <verification_date>March 2021</verification_date>
  <study_first_submitted>August 6, 2019</study_first_submitted>
  <study_first_submitted_qc>August 14, 2019</study_first_submitted_qc>
  <study_first_posted type="Actual">August 15, 2019</study_first_posted>
  <last_update_submitted>March 8, 2021</last_update_submitted>
  <last_update_submitted_qc>March 8, 2021</last_update_submitted_qc>
  <last_update_posted type="Actual">March 10, 2021</last_update_posted>
  <responsible_party>
    <responsible_party_type>Sponsor</responsible_party_type>
  </responsible_party>
  <keyword>Parkinson's</keyword>
  <keyword>Genetics</keyword>
  <keyword>PD Genetics</keyword>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Parkinson Disease</mesh_term>
    <mesh_term>Parkinsonian Disorders</mesh_term>
  </condition_browse>
  <provided_document_section>
    <provided_document>
      <document_type>Informed Consent Form</document_type>
      <document_has_protocol>No</document_has_protocol>
      <document_has_icf>Yes</document_has_icf>
      <document_has_sap>No</document_has_sap>
      <document_date>June 3, 2020</document_date>
      <document_url>https://ClinicalTrials.gov/ProvidedDocs/94/NCT04057794/ICF_000.pdf</document_url>
    </provided_document>
  </provided_document_section>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

